2023 - Global Product Management: Navigating Regulatory Pressures with Automation & Interconnected Data
Date2023-05-12
Deadline2023-05-12
VenueWebinar, USA - United States
KeywordsPharmacovigilance; Automation; Regulatory
Topics/Call fo Papers
Life sciences companies face mounting internal pressures such as inflation, sourcing and manufacturing uncertainty and ever evolving global regulations. Additionally, internal pressures are calling for teams to operate lean and leverage data to solve problems. Together, these external and internal forces present a new wave of challenges for regulatory affairs and operations professionals, especially when managing a sprawling, global product portfolio.
Fortunately, the rapid pace of technology innovation and emerging global data standards provide industry with a new toolset that can be harnessed to bring drugs to market safely and efficiently while achieving commercial success. Life sciences companies can leverage advanced technologies like artificial intelligence (AI) to reduce manual effort and save time by shifting functions like ingestion and tracking of health authority correspondence from mostly manual to automated. Global data standards like ISO Identification of Medicinal Products (IDMP) and HL7’s Fast Healthcare Interoperability Resources (FHIR) promote quick and efficient exchange of information. Interoperability between systems and regions of the world has great potential to lower the cost of operations and create meaningful connections between functional areas such as regulatory and pharmacovigilance.
Join this webinar as ArisGlobal regulatory leaders highlight the potential of intelligent automation and interconnected regulatory data to inform strategic decisions and other key strategies for proactive management of a global product portfolio. They’ll also share use cases and practical steps that regulatory leaders in life sciences can take to ride the next wave of innovation in technology and global data standards.
Fortunately, the rapid pace of technology innovation and emerging global data standards provide industry with a new toolset that can be harnessed to bring drugs to market safely and efficiently while achieving commercial success. Life sciences companies can leverage advanced technologies like artificial intelligence (AI) to reduce manual effort and save time by shifting functions like ingestion and tracking of health authority correspondence from mostly manual to automated. Global data standards like ISO Identification of Medicinal Products (IDMP) and HL7’s Fast Healthcare Interoperability Resources (FHIR) promote quick and efficient exchange of information. Interoperability between systems and regions of the world has great potential to lower the cost of operations and create meaningful connections between functional areas such as regulatory and pharmacovigilance.
Join this webinar as ArisGlobal regulatory leaders highlight the potential of intelligent automation and interconnected regulatory data to inform strategic decisions and other key strategies for proactive management of a global product portfolio. They’ll also share use cases and practical steps that regulatory leaders in life sciences can take to ride the next wave of innovation in technology and global data standards.
Other CFPs
- New Opportunities for Value Creation: How Biotechs Can Succeed in an Increasingly Competitive Market
- Selecting Digital Health Technologies in Decentralized Clinical Trials
- 5th International Conference on New Research Directions on Social Science Economics and Management (RSEM)
- 5th International Conference on Cross Cultural and Regional Studies Business and Public Administration (CRBP)
- MedTech MVP - Venture & Partnering Conference
Last modified: 2023-05-09 05:59:24